Pill dispenser
Latest ASTRAZENECA AB Patents:
- IRAK4 inhibitors
- Pharmaceutical composition
- Methods of treating chronic kidney disease with dapagliflozin
- Pharmaceutical compositions comprising (2S)-n-{(1S)-1-cyano-2-[4-(3-methyl-2-oxo-2,3-dihydro-1,3-benzoxazol-5-yl)phenyl]ethyl}-1,4-oxazepane-2-carboxamide
- Arginase inhibitors and methods of use thereof
Description
The broken lines in the drawings illustrate portions of the pill dispenser that form no part of the claimed design.
Claims
The ornamental design for a pill dispenser, as shown and described.
Referenced Cited
U.S. Patent Documents
6581797 | June 24, 2003 | McKinney, Jr. |
6631805 | October 14, 2003 | Bramen |
D499653 | December 14, 2004 | Karim |
7216776 | May 15, 2007 | Gelardi |
D612594 | March 30, 2010 | Wade |
D688938 | September 3, 2013 | Bailey |
D845615 | April 16, 2019 | Mehregany |
D850097 | June 4, 2019 | Mehregany |
D871055 | December 31, 2019 | Fornarelli |
D908953 | January 26, 2021 | Fornarelli |
D911021 | February 23, 2021 | Al-Bayati |
10940989 | March 9, 2021 | French |
D920659 | June 1, 2021 | Al-Bayati |
Patent History
Patent number: D1036844
Type: Grant
Filed: Jul 8, 2022
Date of Patent: Jul 30, 2024
Assignee: ASTRAZENECA AB (Sodertalje)
Inventor: Lubomir Gradinarsky (Sodertalje)
Primary Examiner: Darlington Ly
Application Number: 29/845,620
Type: Grant
Filed: Jul 8, 2022
Date of Patent: Jul 30, 2024
Assignee: ASTRAZENECA AB (Sodertalje)
Inventor: Lubomir Gradinarsky (Sodertalje)
Primary Examiner: Darlington Ly
Application Number: 29/845,620
Classifications
Current U.S. Class:
D3/203.3